IRADIMED CORP — Director's Dealing 2021

Dec 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2021-12-07

Reporting Person: HAWKINS JAMES B (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-07	Common Stock	A	18743	$1.48	Acquired	36011	Direct
2021-12-07	Common Stock	S	18743	$47.073	Disposed	17268	Direct
2021-12-07	Common Stock	M	4222	—	Acquired	21490	Direct
2021-12-08	Common Stock	A	559	$1.48	Acquired	22049	Direct
2021-12-08	Common Stock	S	559	$48.5	Disposed	21490	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-07	Stock Options (Right to Buy)	$1.48	M	18743	Disposed	2023-12-31	Common Stock (18743)	Direct
2021-12-07	Restricted Stock Units	$	M	4222	Disposed		Common Stock (4222)	Direct
2021-12-07	Restricted Stock Units	$	A	2071	Acquired		Common Stock (2071)	Direct
2021-12-08	Stock Options (Right to Buy)	$1.48	M	559	Disposed	2023-12-31	Common Stock (559)	Direct

Footnotes

F1: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.

F2: This transaction was executed in multiple trades at prices ranging from $46.30 to $48.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020 and 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F4: Restricted Stock Units convert to common stock on a one-for-one basis.

F5: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.